Open menu

Nanotechnology General News

The latest news from academia, regulators
research labs and other things of interest

Posted: July 23, 2007

Antibody targets nanotubes to tumors

(Nanowerk News) Researchers at Memorial Sloan-Kettering Cancer Center have created biocompatible single-walled carbon nanotubes that can target lymphomas and deliver both imaging and therapeutic molecules to these tumors. Reporting its work in the Journal of Nuclear Medicine ("Tumor targeting with antibody-functionalized, radiolabeled carbon nanotubes"), the research team describes the methods it used to create these targeted, multifunctional nanotubes and its initial in vitro and in vivo test results. David Scheinberg, M.D., Ph.D., led the team of investigators.
Starting with water-soluble carbon nanotubes, which recent work has shown are nontoxic to human cells, Scheinberg's group created a construct that included a tumor-targeting antibody, a fluorescent imaging probe, and a radioactive therapeutic agent. Each nanotube, which contained approximately six antibody molecules and 114 radioactive atoms, proved to be stable in human plasma for at least 96 hours and was able to bind to targeted tumor cells. Most importantly, according to the researchers, the chemical linkages binding the radioactive element indium-111 was completely stable in human plasma for the entire 4-day experiment.
Tests using a mouse model of human lymphoma showed that this nanotube construct successfully targeted tumors while avoiding healthy cells. The researchers note that the antibody alone, that is, one not attached to a carbon nanotube, bound better to tumor cells than did the nanotube construct; they believe this difference is a result of not yet optimizing the methods they used to attach the antibodies to the carbon nanotubes.
Source: National Cancer Institute
Subscribe to a free copy of one of our daily
Nanowerk Newsletter Email Digests
with a compilation of all of the day's news.
If you liked this article, please give it a quick review on reddit or StumbleUpon. Thanks!
These articles might interest you as well: